Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_20_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
53 Мб
Скачать
CHAPTER 9
https://t.me/medicina_free
exist as to what hemoglobin levels dictate the need for transfusion. The hematologist will base the decision on the patient’s history and current treatment needs
• Note that, in addition to the sickle cell anemia, this patient’s prognosis is complicated by his intellectual disability and behavior
• The prognosis for continued maintenance of this patient’s dentition is poor, unless the parents make a concerted effort to improve their son’s daily oral hygiene and diet. There are already numerous teeth with very questionable prognosis
• If extraction of teeth is required, the patient is not a good candidate for replacement with fixed prosthesis at this time (due to poor hygiene, soft tissue inflammation). Given the patient’s resistance to intraoral manipulations, his ability to tolerate a removable prosthesis is also questionable
• The patient is not a candidate for orthodontic or orthognathic treatment at this time due to:
Poor oral hygiene Resistant behavior requiring sedation or general anesthesia for any procedures other than cursory examinations and cleanings
N. Complications andAlternative TreatmentPlan
• If the patient’s behavior was cooperative, would he be a good candidate for orthodontic treatment?
• How does the increased probability of osteomyelitis affect the decision to extract or restore teeth with a questionable prognosis?
• What would be the primary postoperative concern in patients requiring extractions?
386 Clinical Cases inPediatric Dentistry
t.me/Dr_Mouayyad_AlbtousH
Self‐Study Questions
https://t.me/medicina_free
PATiEnTs wiTHDisAbiliTiEs
1. Genetically, how does the full sickle cell genotype differ from the genotype for sickle cell trait?
2. Is there an ethnic predilection for sickle cell anemia?
3. What are possible sequelae of a vaso‐occlusive sickle cell crisis?
4. What is the underlying cause for the maxillary enlargement that is present in many individuals with sickle cell anemia?
5.
Name possible precipitating factors for a
vaso‐occlusive crisis
What are some considerations for treating a
6.
patient with sickle cell anemia?
7. What is the hematologic process that results
inavaso‐occlusive sickle cell crisis?
8. What are some intraoral ndings associated
withsickle cell anemia?
Answers are located at the end of the case
Clinical Cases inPediatric Dentistry 387
t.me/Dr_Mouayyad_AlbtousH
CHAPTER 9
https://t.me/medicina_free
Self‐Study Answers
1. In the most common type of sickle cell anemia in the USA, the patients are homozygous for the HbS gene. Individuals with the sickle cell trait are heterozygous for HbS, and are asymptomatic
2. In the USA, sickle cell anemia is seen most frequently in African‐Americans. It may also be present in individuals of Mediterranean, Middle Eastern, African, Indian, Caribbean, and Central and South American decent
3.
Sequelae of a vaso‐occlusive crisis can include
tissue anoxia, tissue necrosis, infarct, and pain. These can occur in any organ system in the body
4. The maxillary enlargement is secondary to heightened bone marrow activity and an increase in the marrow space in the maxilla
5. Factors that may precipitate a vaso‐occlusive crisis in a patient with sickle cell anemia include
hypoxia, infection, stress (such as a dental visit), dehydration, and menstruation
A careful medical history must be elicited,
6.
including a history of vaso‐occlusive crises, transfusions, medications, infections, psychosocial issues, and subsequent damage to organ systems. Treatment recommendations should be discussed, such as the need for antibiotic prophylaxis
7. Sickled red blood cells adhere to vascular
endothelium. This aggregation of cells results in vasoconstriction and inflammation of microvasculature, resulting in a vaso‐occlusive crisis
8.
Some intraoral findings associated with sickle cell
anemia include maxillary enlargement, maxillary incisor proclination, pallor of soft tissues, gingival enlargement, and glossitis
Bibliography
Alves PVM, Alves DKM, de Souza MMG, Torres SR. 2006.
Orthodontic treatment of patients with sickle‐cell anemia. Angle Orthod 76(2):269–73.
American Academy of Pediatrics. 2002. Hematology/Oncology
Committee on Genetics; health supervision for children with sickle cell disease. Pediatrics 109(3):526–35. Reaffirmed February 2016.
da Fonseca MA, Oueis HS, Casamassimo PS. 2007. Sickle
cell anemia: a review for the pediatric dentist. Ped Dent 29(2):159–69.
Licciardello V, Bertuna G, Samperi P. 2007. Craniofacial morphol-
ogy in patients with sickle sell disease: a cephalometric analysis. Eur J Orthodont 29(3):238–42.
Lockhart PB. 2013. Sickle cell anemia. In: Oral Medicine
and Medically Complex Patients, 6th Edition. Oxford: Wiley‐Blackwell. pp. 98–100.
388 Clinical Cases inPediatric Dentistry
t.me/Dr_Mouayyad_AlbtousH
INDEX
https://t.me/medicina_free
21‐mm K‐type endotic files 99 330 bur
39, 44, 51
A
AAPD see American Academy of Pediatric Dentistry
322
®
191
®
367
277
200–205, 207
319–326
319
324
329–330
209–214
301
251
251
256–257
228
234
Ace bandages acute herpetic gingivostomatitis acute lymphoblastic leukemia (ALL)
background information chemotherapy effects dental treatment
oral care acute odontogenic infections acyanotic lesions Acyclovir ADA see American Dental Association adalimumab 350 Adderall ADHD see attention deficit hyperactivity disorder administration
diphenhydramine
epinephrine
general anesthetics
local anesthetics
nitrous oxide/oxygen
preanesthetics 257
sedatives 240 adontogenic infections, acute 209–214 AI see amelogenesis imperfecta airway assessment 238, 244 airway management 244–248
allergic reactions 251
assessment 238, 244
bag‐valve‐masks 246
complications 245
oxygen therapy 246 airway structure 245 ALL see acute lymphoblastic leukemia
allergies
alpha alveolar bone grafts alveolar fractures amalgam restorations amelogenesis imperfecta
11–14 and asthma celiac disease reactions
adrenergic agonists 367
2
339, 341
206–208
249–254
288, 296–297
151
34
215–217
American Academy of Pediatric Dentistry (AAPD) guidelines
caries risk assessment cerebral palsy
361 class II resin restorations dental history first visits
11
7 Frankl Behavioral Rating Scale maximum local anesthetic doses nitrous oxide
232 pharmacological behavior guidance preanesthetics
257 protective base formation radiography
25, 31, 38
transitional dentition
8, 12
45–46
223
228
239
80
31, 38–39, 43
American College of Chest Physicians guidelines, congenital
heart disease 305
American Dental Association (ADA) guidelines
congenital heart disease 305 mouth guards 150
American Society of Anesthesiologists (ASA) classifica-
tions 238, 356
aminocaproic acid (Amicar
®
) 314 aminosalicylates (ASA) 350 amoxicillin 211 amphetamines 367 analgesics
asthmatic patients 344 hemophiliac patients 315 liver transplant patients 329
Clinical Cases in Pediatric Dentistry, Second Edition. Edited by Amr M. Moursi. © 2020 John Wiley & Sons, Inc. Published 2020 by John Wiley & Sons, Inc. Companion website: www.wiley.com/go/moursi/pediatrics
389
t.me/Dr_Mouayyad_AlbtousH
Index
https://t.me/medicina_free
anaphylaxis 250–251 ANB angle
281 anesthesia see general anesthesia; local anesthesia angular cheilitis ankylosis anterior crossbite anterior zirconia crowns
200
168–170
279–284
71–76
antibiotics
avulsed teeth Crohn’s disease cystic fibrosis
facial infections anticoagulant therapy antifungal medications
169
350
309
211, 212
305
201
anxious patients see also behavior guidance
asthmatics
behavioral rating
communication techniques
desensitization
medications
343
223
224
380
231–236, 241
apexifications
risks and complications 119
root end closures
technique aphthous stomatitis
115–120
118
206–207
apical periodontitis
definition 128
necrotic tooth revascularization
TM
Arestin aripiprazole articaine
170
379
228
127–132
ASA see American Society of Anesthesiologists;
aminosalicylates ASD see atrial septal defect; autism spectrum disorder assessment see also diagnosis; differential diagnosis
asthma
341
orthodontic
asthma
assessment atopy attack management background information classifications
260–261
30, 233, 339–346
341
342
344
340
340 general anesthesia 343 management and treatment
340, 342, 343 oral implications 342 sedation 343
asymptomatic apical periodontitis 128 atomoxetine (Strattera) 367 atopy and asthma 342 atrial septal defect (ASD) 301 atrophic candidiasis 200 attention deficit hyperactivity disorder (ADHD)
365–370 background information 366 comorbidities 366 management 367
autism spectrum disorder (ASD) 377–382
background information 378 behavior guidance 380
diagnosis oral considerations
378
379
avulsions
flowchart management outcomes permanent teeth transport treatment
azathioprine
177
168
170
167–172
169
168
330, 350
B
bag‐valve‐masks 246 band and loop spacers beginning brushing
270
8
behavioral disorders
attention deficit hyperactivity disorder autism spectrum disorder
behavioral rating
223
behavior guidance/management
airway management asthma
343 autism spectrum disorder desensitization
380 functional inquiries general anesthesia
377–382
221–258
243–248
380
222 255–258
intraoperative pain management
®
74
224
231–236
221–226
237–242
224
337
277
241
30
281 269–274
350
38
30–31
31, 38, 43
modeling nitrous oxide/oxygen sedation nonpharmacological pharmacological positive reinforcement type 1 diabetes
behavior modification benzodiazepines beta agonists bilateral crossbite correction bilateral space management BioCem biopsy, Crohn’s disease bitewing radiographs
incipient decay transitional dentition
365–370
227–230
blood disorders
acute lymphoblastic leukemia 319–326 hemophilia A 313–318 sickle cell disease 233, 383–388
blood sugar levels, diabetes 334, 335 bluegrass habit appliance 276 bone grafting, cleft lip and palate 288, 295 BPD see bronchopulmonary dysplasia Brodsky Scale 238, 243 bronchopulmonary dysplasia (BPD) 359–364 brushing, start of 7 budesonide 350 bupivacaine, maximum doses 228
C
calcium hydroxide
methodology 112
390 Clinical Cases inPediatric Dentistry
t.me/Dr_Mouayyad_AlbtousH
Index
https://t.me/medicina_free
root end closure–apexifications 115–120 vs. mineral trioxide aggregate
candidiasis
types carbamazepine carbide burs
199–204, 342
200
373
45, 50
124
cardiovascular abnormalities, 23, 62 see also blood disorders
anticoagulant therapy
atrial septal defect
congenital heart disease
Ebstein’s anomaly
infective endocarditis
tetralogy of Fallot
305
301
300–306
354
303
23, 301
caries
cervical pulpotomies
class II glass ionomer restorations
class II resin restorations
class IV resin restorations
class V glass ionomer restorations
class V resin restorations
deep lesion removal
general anesthesia
incipient decay resin restoration
interim restorations
partial pulpotomies
risk assessment
selective removal
silver diamine fluoride Caries‐Risk Assessment Tool (CAT)
91–92
37–42
43–48
61–66
49–54
55–60
80
23–28
29–36
19–22, 51
103–108
8, 12, 303
78–84
15–18
303 CAT, see also Caries‐Risk Assessment Tool Catapres
®
367
cavity preparation
class II glass ionomer 39 class II resin restorations class V glass ionomer class V resin restorations resin restoration
32, 39
44
51
58
CD see Crohn’s disease celiac disease 205–208 cell‐mediated hypersensitivity reactions cementation, zirconia crowns central papillary atrophy cerebral palsy
359–364
72
200
250
background information 360 oral medicine 361 sedation 361 ventilation
359–360
cervical pulpotomy in cariously exposed primary
molars 91–96 CF see cystic fibrosis CHD see congenital heart disease chemotherapy see also acute lymphoblastic leukemia
acute and long‐term effects 324
mucositis 324 chicken pox 207 chlorhexidine 116, 117, 123 chronic atrophic candidiasis 200 chronic disease management 16 ciprofloxacin 129, 350 classifications
American Society of Anesthesiologists asthma seizure disorders
339
372 class II glass ionomer restorations class II resin restorations class IV resin restorations
43–48
61–66 class V glass ionomer restorations class V resin restorations cleft lip and palate
bone grafting complications diagnosis embryology etiology evaluation incidence management oral health
288, 296–297
290, 296–297
287–288, 295
286
286
285–292
286
286–288, 295–296
294 oral manifestations orthodontics
293–298 prenatal diagnosis presurgical treatment sequential treatment method
clonidine (Catapres clotting disorders, hemophilia A
55–60
285–298
295
286
287
®
) 367
288
313–318
237, 362
37–41
49–54
combined presentation attention deficit hyperactivity disorder
(ADHD‐C) 366
communication techniques, anxious patients
223
comorbidities
attention deficit hyperactivity disorder 366 natal teeth
complex pulp therapy
cervical pulpotomies indirect partial pulpotomies revascularization root canal treatments root end closure–apexification with calcium hydroxide root end closure with mineral trioxide aggregate selective caries removal
complicated crown fractures
3
77–132
91–96
77–84
85–90, 103–108
127–132
97–102
115–120
121–126
77–84
87, 143–148, 177
complications
airways 245 asthma 343 attention deficit hyperactivity disorder medications 367 cerebral palsy 361 of chemotherapy 324 cleft lip and palate 289 congenital heart disease 301 crossbite corrections 282 cystic fibrosis 308–310 Down syndrome 355 general anesthesia 256 head and neck infections
211 hemophilia 315 intrusion injuries 163 liver transplants 329, 330 local anesthesia 229 nitrous oxide 233 seizure disorders 373, 374
Clinical Cases inPediatric Dentistry 391
t.me/Dr_Mouayyad_AlbtousH
Index
https://t.me/medicina_free
complications (cont’d)
of trauma 136, 140–141 type 1 diabetes
Concerta
®
337, 355
367
cone beam computed tomography (CBCT)
cleft lip and palate orthodontic evaluation
295
261, 295
congenital conditions
amelogenesis imperfecta bronchopulmonary dysplasia cerebral palsy
359–364 cleft lip and palate Down syndrome
354–358
sickle cell disease
congenital heart disease (CHD)
anticoagulant therapy background information caries risk
301–302 infective endocarditis medical consultation
conscious sedation
51, 231–236, 240, 343 see also nitrous
215–220
359–364
285–298
233, 383–388
299–306
305
301
303
299, 301
oxide/oxygen sedation conservation, of tooth structure 34 contraindications
class II glass ionomer restorations 37 class II resin restorations class V glass ionomer cement general anesthesia nitrous oxide
232, 309 nonsteroidal anti‐inflammatory drugs partial pulpotomies pharmacological behavior guidance primary teeth pulpotomies resin restorations zirconia crowns
32
74 corticosteroids, asthma Coumadin
®
305
39
51
256, 309
315, 329
88
238
92, 98–99
342
craniofacial anomalies
chemotherapy effects 324 cleft lip and palate
245
cricoid Crohn’s disease (CD)
285–298
347–352 background information 347–338 diagnosis 349 management 350 oral manifestations 349 presentation
349
treatment 349, 350
crossbite, interceptive orthodontics 279–284 crowding see also space management
space analysis 270–271 space management 271
crown fractures
complicated 87, 143–148, 177 flowchart 177 treatment methods 145, 177
crowns
amelogenesis imperfecta 217 strip‐type 67–70 zirconia 71–76
Cvek pulpotomy see partial pulpotomies cyanotic conditions, congenital heart disease cyclosporine Cyklokapron cystic fibrosis (CF)
background information medical history oral manifestations treatment considerations
330
®
314
307–312
308
307
309
309
cysts
eruption mucocele
cytotoxic hypersensitivity reactions
183–188
195–198
250
D
DDAVP® see desmopressin decoronation, avulsions deep lesions, caries removal delayed hypersensitivity reactions dental history see also medical history;
patient history
avulsions
167–168
functional inquiries
8, 12
infants
79
pain space management
134, 139–140, 143, 155
trauma
dentin
80 dentinal bonding agents dentoalveolar luxation injuries desensitization
380 desmopressin (DDAVP development see growth and development developmental abnormalities
amelogenesis imperfecta
natal/neonatal teeth diabetes, type 1 diagnosis
autism spectrum disorder 377
candidiasis
201 celiac disease cleft lip and palate Crohn’s disease 350 crossbites 280–281 eruption cysts 185
diamond burs 51, 73 diazepam 241 differential diagnosis
acute odontogenic infections amelogenesis imperfecta 216 candidiasis 199 celiac disease 205, 207 Crohn’s disease 350 eruption cysts 184, 185 lower lip masses 195 primary herpetic gingivostomatitis 190, 206
®
Dilantin
373 diphenhydramine 251 disabilities 353–388
attention deficit hyperactivity disorder 365–366
169–170
80
222
265
45
149–154, 177
®
) 314
215–217
1–5, 183–188
333–338
205
286–287, 295–296
250
211
301
392 Clinical Cases inPediatric Dentistry
t.me/Dr_Mouayyad_AlbtousH
Index
https://t.me/medicina_free
autism spectrum disorder 377–382 bronchopulmonary dysplasia cerebral palsy Down syndrome intellectual seizure disorder
sickle cell disease discharge criteria, pharmacological behavior guidance discoloration disinfection of root canals distal shoes distraction techniques documentation, orthodontic Down syndrome
background information
complications
medical history
orofacial pathology
sedation doxycycline drooling DynaCleft
361
359–364
353–358
371–376, 383–388
371–376
383–388
135, 141, 329
267
224
23–25, 301, 353–358
356
354
355
356
169, 170
287, 288
359–364
240
117
259–264
354
E
EAPD, see also European Academy of Pediatric Dentistry early oral health
dental history
first visits
fluoride assessment
general anesthesia
healthy children
intraoral exams
medically compromised
perinatal
radiographs
silver diamine fluoride Ebstein’s anomaly embryology, cleft lip and palate endocarditis, infective enoxaparin sodium epilepsy, 371 see also seizure disorders epinephrine
administration 251
with lidocaine 32, 57
with xylocaine 44 eruption cysts 183–188 erythematous candidiasis 200 European Academy of Pediatric Dentistry (EAPD) guidelines,
radiography 31 evaluation, orthodontic 56, 259–261 executive function 366 see also attention deficit
hyperactivity disorder extremely low birth weight 359 extrusive luxation injuries 155–160, 177, 179
1–28 7
7–14
11–12
23–28
7–10
11
11–14
1–5
24
15–18
354
286
303
305
F
facial infections 209–214 FC see formocresol ferric sulfate (FS) pulpotomies 93 fibrin sealants 305
first generation cephalosporins first visits
caries risk assessment eruption cysts functional inquiries healthy children medically compromised perinatal
timing fluconazole fluoride assessment fluoride varnish food allergies
celiac disease
and GERD formocresol (FC) pulpotomies formoterol fostered children Frankl Behavioral Rating Scale FS see ferric sulfate full coronal restoration functional enquiries fungal infections
candidiasis 199–204
medications
1–14
183–185
222
7–10
1–5, 183–188
7
201
11–13
57
11–14
205–208
13
342
162
72
222
201
212
8, 11–14
11–14
102
223
G
gastroesophageal reflux disease (GERD) 11–14
and food allergies gastrointestinal disorders
celiac disease 205–208
Crohn’s disease
cystic fibrosis
liver transplants G‐CSF see granulocyte colony stimulating factor general anesthesia
administration
asthma
behavior guidance
complications
indications/contraindications
infant caries
liver transplant patients 329
preanesthetics
type 1 diabetes 337
zirconia crowns 72 GERD see gastroesophageal reflux disease GIC see glass ionomer cement gingivostomatitis, primary herpetic 189–194 glass ionomer cement (GIC)
class II 37–40, 46
class V 49–54
properties 50
selection rationale 38, 46 glucocorticoids 330, 350 gluten sensitivity 205–208 granulocyte colony stimulating factor (G‐CSF) 324 growth and development 260–298
chemotherapy effects 324
cleft lip and palate 285–298
343–344
13
347–352
308
327–332
256–257
255–258
256
256, 309
23–28
257
Clinical Cases inPediatric Dentistry 393
t.me/Dr_Mouayyad_AlbtousH
Index
https://t.me/medicina_free
growth and development (cont’d)
evaluation 285–292 orthodontics early primary second molar loss habit appliances leeway space mixed dentition anterior crossbite bilateral space management orthodontic documentation, evaluation and
assessment primary dentition loss, early space analysis space management bilateral, mixed dentition early primary second molar loss
guanfacine (Tenex/Intuniv)
293–297
265–268
275–278
270
279–284
269–274
260–264
265–268
270–271
265–274
269–274
265–268
367
H
habit appliances 275–278 Hank’s Balanced Salt Solution (HBSS) harmatomas HBSS see Hank’s Balanced Salt Solution healing, root fractures healthy children, first visits heart disease, congenital heart murmurs hemophilia
dental treatment management surgical treatment
heparin sodium herpetic gingivostomatitis high body mass index patients hospital admission, facial infections hyperactivity
disorder
hyperglycemia 335 hyperplastic candidiasis hypoglycemia hypotonia of tongue and perioral musculature
184
141, 157
7–10
299–306
61–62
313–318
315
313–314
315
305
189–194
365 see also attention deficit hyperactivity
200
55, 335
168
31, 244
211
361
I
IBD see inflammatory bowel disease ICS see inhaled corticosteroids IE see infective endocarditis imidazoles 201 immature permanent incisors, revascularization 127–132 immature permanent molars
partial pulpotomies 103–108 pulpotomy with mineral trioxide aggregate 109–114
immediate hypersensitivity reactions 250 immune complex hypersensitivity reactions 250 immunocompromised patients
acute lymphoblastic leukemia 322–323 liver transplants 330
immunological causes
allergic reactions 250 gingivostomatitis 190 swelling 210
immunosuppressants impulsivity
inattention
incidence
amelogenesis imperfecta asthma
Candida albicans
celiac disease cleft lip and palate comorbid attention deficit hyperactivity disorders congenital heart disease Crohn’s disease cystic fibrosis hemophilia latex anaphylaxis natal teeth recurrent herpes simplex virus salivary gland tumors sickle cell disease
type 1 diabetes incipient decay, resin restoration incisors
avulsions 167–172, 177
complicated crown fractures
dentoalveolar luxation injuries
and extrusive luxation
intrusion injuries
necrotic, revascularization
partial pulpotomies
in primary dentition
root end closure–apexification with calcium
root end closures with mineral trioxide aggregate
root fractures indications
class II glass ionomer restorations
class II resin restorations
class V glass ionomer restorations
early orthodontics
general anesthesia
interim therapeutic restorations 50
liver transplants 328
nitrous oxide 232
partial pulpotomies 87, 104
primary teeth pulpotomies 92, 98–99
revascularization 128 indirect pulp treatment (IPT) infants 7–28 see also neonatal teeth
caries risk assessment 8, 11–14
dental history 7
fluoride assessment 11–13
general anesthesia 23–28
healthy 7–9
interim restorations 19–22
intraoral exams 12
medically compromised 11–14
radiographs 25
silver diamine fluoride 15–18
366 see also attention deficit hyperactivity
disorder
366 see also attention deficit hyperactivity
disorder
339
313
185
hydroxide 115–120
330, 350
216
201
206
285–286
301
347
308
250
191
195
383–388
333
30–36
143–148, 177
149–154, 177
155–158, 177, 179
133–138, 161–166, 177
127–132
85–90
139–142
38
46
51
282
256
77–84
365–361
121–126
394 Clinical Cases inPediatric Dentistry
t.me/Dr_Mouayyad_AlbtousH
Index
https://t.me/medicina_free
infections
acute odontogenic candidiasis oral ulcers
199–204
207
primary herpetic gingivostomatitis
infective endocarditis (IE)
209–214
189–194
303
inflammation see also swelling
gingivostomatitis primary herpetic gingivostomatitis as swelling
inflammatory bowel disease (IBD)
190
189–194, 207
210
348 see also Crohn’s
disease inflammatory hyperplasias inflammatory root resorption infliximab
350 informed consent, orthodontics inhaled corticosteroids (ICS) initial management, cleft lip and palate innocent heart murmurs insulin‐dependent diabetes mellitus
184
170
262
342
286, 287
62
333–338 see also type 1
diabetes intellectual disability 371–376, 383–388 interceptive orthodontics
anterior crossbites 279–284
habit appliances interdisciplinary teams, cleft lip and palate interim therapeutic restorations (ITR) intraoperative pain management
275–278
286
19–22, 50
227–230
intraoral exams
crown fractures 143, 177
12
infants
trauma
140, 150
intrusion injuries
complications 163
®
367
177
161–166
133–138
flowchart
permanent incisors
primary incisors Intuniv IPT see indirect pulp treatment ITR see interim therapeutic restorations
K
ketoacidosis 335 K‐type endodontic files 99
L
LABA see long‐acting beta2‐agonists LAMA see long‐acting muscarinic antagonists latex allergy leeway space 270 leukotriene receptor agonists (LTRA) 342 lidocaine
class V resin restorations 32
incipient decay restoration 32
liver transplant patients 329, 330
maximum doses 228 lip taping 287, 288 liver transplants 327–332
background information 328
dental management 330
250
indications medical history treatment considerations
328
327–328
330
local anesthesia
class II resin restorations class V resin restorations complications
229 incipient decay restoration intraoperative pain management liver transplant patients maximum doses
long‐acting beta
229
‐agonists (LABA) 342
2
44 32
32
227–230
329
long‐acting muscarinic antagonists (LAMA) low birth weight lower anterior crowding
359
271 LTRA see leukotriene receptor agonists luxation injuries
dentoalveolar and root fractures splinting
lymphoblastic leukemia, acute
149–154, 180
155–160, 178, 180
150–151
319–326
M
Mallampati scores 244 management
asthma 339, 340, 342 attention deficit hyperactivity disorder avulsions cleft lip and palate Crohn’s disease facial infections hemophilia A herpetic lesions liver transplant patients seizures
168–169, 181
286–287, 295
348
211–212
313–314
190
330
374 mandibular shifts, crossbite corrections material selection
class II resin restorations 46 class V resin restorations glass ionomer cements
maxillary orthopedics
58
38
287
medical emergencies
anaphylaxis 251 asthma 344 bag‐valve‐masks 246 oxygen therapy 246 seizures 374
medical history 11
acute lymphoblastic leukemia 319–320 allergies 251 asthma 30, 339 avulsions 167 cleft lip and palate 286 congenital heart disease
301 cystic fibrosis 307–308 Down syndrome 24, 354 heart murmurs 62 hemophilia A 313 hypoglycemia 55 liver transplants 327
367
281
342
Clinical Cases inPediatric Dentistry 395
t.me/Dr_Mouayyad_AlbtousH
Соседние файлы в папке Библиотека им академика М.И. Перельмана